MedPath

Cefdinir

CEFDINIR CAPSULES, USP   300 mg Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefdinir and other antibacterial drugs, cefdinir should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Approved
Approval ID

63aa0304-574f-4d37-9fb4-26ffb058fbec

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 20, 2025

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefdinir

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-8968
Application NumberANDA210220
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefdinir
Product Specifications
Route of AdministrationORAL
Effective DateAugust 20, 2025
FDA Product Classification

INGREDIENTS (11)

CEFDINIRActive
Quantity: 300 mg in 1 1
Code: CI0FAO63WC
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYOXYL 40 STEARATEInactive
Code: 13A4J4NH9I
Classification: IACT
POTASSIUM HYDROXIDEInactive
Code: WZH3C48M4T
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
CARBOXYMETHYLCELLULOSE CALCIUMInactive
Code: UTY7PDF93L
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 12/30/2011

Cefdinir 300mg Capsule#20 Alkem

Label

DESCRIPTION SECTION

LOINC: 34089-3Updated: 6/28/2022

DESCRIPTION

Cefdinir capsules, USP contain the active ingredient cefdinir, an extended- spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6α,7β (Z)]]-7-[[(2-amino-4 thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid. It is slightly soluble in dilute hydrochloric acid and sparingly soluble in 0.1 M pH 7.0 phosphate buffer.The empirical formula is C14H13N5O5S2 and the molecular weight is 395.42. Cefdinir has the structural formula shown below:
![cefdinir-structure](/dailymed/image.cfm?name=cefdinir- structure.jpg&id=894010)

Cefdinir capsules, USP contain 300 mg cefdinir and the following inactive ingredients:

carboxymethylcellulose calcium, polyoxyl 40 stearate, colloidal silicone dioxide and magnesium stearate.

The capsule shells contain FD&C Blue #2; gelatin, titanium dioxide, gelatin and water. Imprinting ink components shellac, Black Iron Oxide and potassium hydroxide.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 8/20/2025

HOW SUPPLIED

Cefdinir capsules, USP containing 300 mg cefdinir, having off white to light yellow colour granular powder filled in size “0” hard gelatin capsules, blue opaque cap imprinted “A041” with black ink and blue opaque body imprinted “300” with black ink.

NDC: 63629-8968-1: 20 CAPSULEs in a BOTTLE

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

Repackaged/Relabeled by:
Bryant Ranch Prepack, Inc.
Burbank, CA 91504

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefdinir - FDA Drug Approval Details